Upload Avatar (500 x 500)
Shengying Qin
chinsir@163.com
Chinese, English
Shanghai
Shanghai Jiao Tong University
Life Sciences
  • 2005 - PhD from Shanghai Jiao Tong University
  • 2014-2015 - Visiting Scholar at Harvard University and Broad Institute
  • Director at Bio-X Institutes, Shanghai Jiao Tong University
  • Current - Director at Bio-X Institutes, Shanghai Jiao Tong University
  • 2014-2015 - Visiting Scholar at Harvard University and Broad Institute
  • International Human Genetics Society Young Researcher Award
  • Second Prize in National University Biology Micro-course Competition
  • SMC Excellent Young Teacher Award at Shanghai Jiao Tong University
  • First Prize in Outstanding Postdoctoral Award Fund
Pharmacogenomics and Personalized Medicine
Birth Defects and Disease Genomics
  • Improving polygenic prediction in ancestrally diverse populations, Shengying Qin et al., 2022
  • Multi-omics analysis identifies rare variation in leptin/PPAR gene sets and hypermethylation of ABCG1 contribute to antipsychotics-induced metabolic syndromes, Shengying Qin et al., 2022
  • MiR143-3p-mediated neuregulin-1-dependent mitochondrial dysfunction contributes to olanzapine resistance in refractory schizophrenia, Shengying Qin et al., 2022
Pharmacogenomics Personalized Medicine Birth Defects Disease Genomics Molecular Markers Drug Response Molecular Mechanisms High-Throughput Technologies Disease Treatment Precision Medicine

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.